CUSIP: 29970R105
Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
883,883
-
Share change
-
+883,883
-
Total reported value
-
$5,119,000
-
Price per share
-
$5.90
-
Number of holders
-
9
-
Value change
-
+$5,119,000
-
Number of buys
-
9
Quarterly Holders Quick Answers
What is CUSIP 29970R105?
CUSIP 29970R105 identifies EVAX - EVAXION BIOTECH A S - ADS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29970R105:
Institutional Holders of EVAXION BIOTECH A S - ADS (EVAX) as of Q1 2021
As of 31 Mar 2021,
EVAXION BIOTECH A S - ADS (EVAX) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
883,883 shares.
The largest 9 holders included
Maven Securities LTD, Granite Point Capital Management, L.P., LUMINUS MANAGEMENT LLC, Alyeska Investment Group, L.P., Telemetry Investments, L.L.C., Kepos Capital LP, Altium Capital Management LP, ETF MANAGERS GROUP, LLC, and ADVISOR GROUP HOLDINGS, INC..
This page lists
9
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.